(LNA) LNA Sante - Ratings and Ratios

LNA Santé SA is a France-based healthcare services provider specializing in the operation and management of diverse health establishments. The company offers a comprehensive range of services, including retirement homes, medical and rehabilitation care, home hospitalization, surgical procedures, mental health clinics, and general health centers. Established in 1990, LNA Santé SA has built a reputation for delivering integrated healthcare solutions, addressing the needs of patients across various stages of life and medical conditions. Headquartered in Vertou, France, the company operates a network of facilities designed to provide accessible and high-quality care to its patients.

As part of its mission, LNA Santé SA emphasizes a patient-centric approach, focusing on personalized care and rehabilitation programs tailored to individual needs. The companys facilities are equipped with modern medical technology and staffed by trained healthcare professionals, ensuring a high standard of service delivery. Over the years, LNA Santé SA has expanded its reach, contributing significantly to the healthcare landscape in France and beyond.

Ticker Symbol: LNA Exchange: PA Type: common stock Country Origin: France GICS Sub Industry: Health Care Facilities Average Volume 20d: 2973 Last Price: 25.30 SMA 20: 24.98 SMA 50: 23.66 SMA 200: 24.27 ATR: 0.46 Market Cap: 262.00M EUR P/E: 10.69 P/E Forward: 0.00 P/B: 0.85 P/S: 0.34 RoE: 11.65 3-Month Forecast Based on the provided data, LNA Santé SA is expected to maintain stability in the short term, with potential upside driven by its defensive healthcare sector positioning. - Technical Outlook: The stock is trading above its SMA 50 (23.66) and SMA 200 (24.27), indicating a bullish trend. The SMA 20 (24.98) is slightly below the last price (25.30), suggesting near-term momentum. ATR of 0.46 reflects moderate volatility, which may support a sideways-to-upward movement. - Fundamental Outlook: A P/E of 10.69 and P/B of 0.85 suggest undervaluation relative to peers, with room for multiple expansion. The RoE of 11.65 highlights efficient profitability, which could attract investor interest. However, the lack of forward P/E data introduces uncertainty about future earnings expectations. Overall, LNA Santé SA is likely to see gradual price appreciation over the next three months, supported by its strong financial metrics and sector resilience.